BPC Floats Innovation Proposals; Alexander Asks For 10 Specifics

The Bipartisan Policy Center (BPC) offered a set of recommendations to Congress Monday (July 27) designed to spur innovation by reforming FDA policies, with some of the proposed reforms tracking closely with the 21st Century Cures legislation that overwhelmingly passed the House earlier this month and others going beyond the House bill. The group recommends the Senate health committee broach such controversial areas as off-label promotion, drug exclusivity, laboratory-developed tests and combination products, among others. BPC said in March that...